IntraBio Inc. today announced positive topline results from its pivotal Phase III IB1001-303 clinical trial, "Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Randomized, ...
Clinical Trials Arena on MSN
IntraBio’s ataxia-telangiectasia drug meets endpoints in pivotal trial
If approved, levacetylleucine could become the first therapy on the market for ataxia-telangiectasia.
As IntraBio works to grow the global treatment market for Aqneursa in Niemann-Pick disease type C, the company is already ...
IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA® (levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...
There was an almost four-fold increase in the number of people being treated for the addictive use of volatile inhalants such as aerosols and nitrous oxide in a three-year period, an Oireachtas ...
Las Vegas News on MSN
10 foods that were banned in some countries (and why)
Kinder Surprise Eggs – The Chocolate Treat America Can’t Have Kinder Surprise Eggs – The Chocolate Treat America Can’t Have ...
Six poster presentations highlight CARVYKTI® efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, ...
Attention-Deficit Hyperactivity Disorder, or ADHD, affects tens of millions of people in the U.S.About one in nine children ...
Non-traumatic musculoskeletal disorders significantly impact the physical development, functional independence, and overall ...
Wendy Wisner is a journalist and international board certified lactation consultant (IBCLC). She has written about all things pregnancy, maternal/child health, parenting, and general health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results